Episode 3 | Racing Against Resistance: The Future of Antimicrobial Innovation

Rienk Pypstra, tranScrip’s Chief Medical Officer, joins Marc Lemonnier, Chief Executive Officer of Antabio, to discuss the global threat of antimicrobial resistance. They’ll explore why innovation must outpace bacterial evolution, how economic incentives can sustain antibiotic R&D, and why agility, collaboration, resilience and strategic vision are essential to overcoming resistance and driving the future of AMR.